Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #224147 on Amarin Corp Plc (AMRN)
rafunrafun
11/10/19 4:22 PM
#224156 RE: Atom0aks #224147
That's reasonable. The text in bold is indeed what I am predicting to be the question that's presented to the committee.
But the justification behind that is weak. (On the primary 5 pt MACE the interaction term was p=0.14 and the protocol says below 0.15 would be considered significant, so yes, there is evidence in 5 pt MACE that there is a difference in efficacy between populations. The counter argument to that would be that the FDA focuses on Hard MACE. And the Hard MACE primary prevention data is compelling (with no SS interaction test).